首页 > 抗体蛋白 > 抗体
Purified anti-H2A.X Phospho (Ser139) Antibody
产品名称:
Purified anti-H2A.X Phospho (Ser139) Antibody
产品类别:
抗体
产品编号:
613401
产品应用:
613401
[价格]
规格 价格 库存
25µg ¥ 1416 1

产品详情

Product Details

Verified Reactivity
Human, Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Modified peptide
Formulation
This H2A.X antibody is provided in phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. Final antibody concentration is 0.5 mg/ml.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
Upon receipt, store between 2°C and 8°C.
Application

WB - Quality tested
ICC - Verified
ICFC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by Western blotting. Western blotting, suggested working dilution(s): Use 5 ?g antibody per 5 ml antibody dilution buffer for each mini-gel. For immunocytochemistry, a concentration range of 1.0 - 4.0 μg/ml is recommended. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats of this clone) include: immunohistochemistry on paraffin embedded sections2, immunofluorescence microscopy3-9, Western blotting 10-12, and flow cytometry1,13. Clone 2F3 cross-reacts with mouse4.

Intracellular staining protocol for Anti-H2A.X-Phosphorylated (Ser139) Antibody for Flow Cytometry

1. Prepare 70% absolute ethanol. Chill solution by storing at -20°C.
2. Prepare cells of interest.
3. Wash 1X with PBS, centrifuge at 350g for 5 min.
4. Discard the supernatant and vortex to loosen cell pellet.
5. Add pre-cooled 70% ethanol drop by drop, while vortexing.
6. Incubate at -20°C for 60 minutes.
7. Wash 3X with BioLegend Cell Staining Buffer and resuspend the cells at 0.5-1 X 107 cells/ml in the cell staining buffer.
8. Perform immunofluorescent staining for flow cytometry.

Application References

(PubMed link indicates BioLegend citation)
  1. Jha JC, et al. 2013. J. Virol. 87:5255. (FC) PubMed
  2. Akbay A, et al. 2008. Am J Pathol. 173:536. (IHC) PubMed
  3. Mochizuki K, et al.2008.J cell Sci.121:2148. (IF) PubMed
  4. Xiao R, et al. 2007. Mol Cell Biol.27:5393. (IF) PubMed
  5. Rossi DJ, et al. 2007. Nature. 447:725. (IF) PubMed
  6. Loidl J, et al. 2009. Mol Cell Biol. 20:2048. (IF) PubMed
  7. Beels L, et al. 2009. Circulation. 120:1903. (IF) PubMed
  8. Suzuki K, et al. 2010. Nucleic Acids Res. 38:e129. (IF) PubMed
  9. Lukaszewicz A. 2010. Chromasoma Apr 27. [Epub ahead of print] (IF) PubMed
  10. Yamada C, et al. 2010 J. Biol. Chem. 285:16693. (WB) PubMed
  11. Bu Y, et al. 2010, Biochem Biophys Res Commun. 397:157. (WB) PubMed
  12. Massignan T, et al. 2010. J. Biol Chem. 285:7752. (WB) PubMed
  13. Banath JP, et al. 2010. BMC Cancer 10:4 (FC)
  14. Zhang M., et al. 2011. Cancer Res. 23:7155. PubMed
  15. Kuefner MA, et al. 2012. Radiology 264:59. PubMed
  16. Yoshihara Y, et al. 2012. Biochem Biophys Res Cmmun. 421:57. PubMed
  17. Titus S, et al. 2013. Sci Transl Med. 13:21. PubMed
  18. Crown KN, et al. 2013. G3. 6:1927. PubMed
  19. Schenkwein D, et al. 2013. Nucleic Acids Res. 41:e61. PubMed
  20. Zhadanova NS, et al. 2014. Mol Cell Biol. 34:2786. PubMed
  21. Horrell SA, et al. 2014. Eukaryot Cell. 13:1300. PubMed
  22. Maya-Mendoza A, et al. 2015. Mol Oncol. 9:601. PubMed
Product Citations
  1. Li M, et al. 2011. Mol Cell Biol. 31:2090. PubMed
  2. Kuefner M, et al. 2012. Radiology. 264:59:00. PubMed
  3. Chomiak AA, et al. 2022. iScience. 25:104354. PubMed
  4. Feng W, et al. 2017. Proc Natl Acad Sci U S A. 114(2):406-411. PubMed
  5. Nyeste A, et al. 2016. J Biol Chem. 291: 4473 - 4486. PubMed
  6. Jha H, et al. 2013. J Virol. 87:5255. PubMed
  7. Xiao R, et al. 2007. Mol Cell Biol. 27:5393. PubMed
  8. Teloni F et al. 2019. Mol Cell. 73(4):670-683 . PubMed
  9. Wang C, et al. 2020. DNA Repair (Amst). 95:102946. PubMed
  10. Nomura D, et al. 2021. Biol Pharm Bull. 44:642. PubMed
  11. Zhong B, et al. 2019. Am J Cancer Res. 9:79. PubMed
  12. Wang R, et al. 2020. Proc Natl Acad Sci U S A. 117:33436. PubMed
  13. Suzuki T, et al. 2021. Nucleic Acids Res. 49:e40. PubMed
  14. Roeschert I, et al. 2021. Nat Cancer. 2:312. PubMed
  15. Yamauchi M, et al. 2017. Sci Rep. 7:41812. PubMed
  16. Kaul Z, et al. 2011. EMBO Rep. 13:52. PubMed
  17. Taglialatela A et al. 2017. Molecular cell. 68(2):414-430 . PubMed
  18. Murray-Nerger LA, et al. 2021. Nucleic Acids Res. 49:2044. PubMed
  19. Stoyas CA, et al. 2020. Neuron. 630:105. PubMed
  20. Maffucci P, et al. 2018. J Clin Invest. 128:5489. PubMed
  21. Hopp AK, et al. 2021. Mol Cell. 81:340. PubMed
  22. Gatti M, et al. 2020. Cell Rep. 32:107985. PubMed
  23. Kohutova A, et al. 2019. FASEB J. :fj201801877RR. PubMed
  24. Yoshihara Y, et al. 2012. Biochem Biophys Res Commun. 421:57. PubMed
  25. Maya-Mendoza A, et al. 2015. Mol Oncol. 9:601. PubMed
  26. Pedersen R, et al. 2016. Nat Commun. 7:13887. PubMed
  27. Massonneau J, et al. 2018. FEBS Open Bio. 8:416. PubMed
  28. Kwasna D et al. 2018. Molecular cell. 70(1):150-164 . PubMed
  29. Mlcochova P, et al. 2020. Cell Rep. 30:3972. PubMed
  30. Michelena J, et al. 2021. Life Sci Alliance. 4: . PubMed
  31. Pelicci S, et al. 2022. Nanomaterials (Basel). 12. PubMed
  32. Schneider MWG, et al. 2022. Nature. 609:183. PubMed
  33. Gavande NS, et al. 2020. Nucleic Acids Res. 48:11536. PubMed
  34. Chalker S 2014. Eukaryot Cell. 13:1300. PubMed
  35. Friedman J, et al. 2018. J Immunother Cancer. 6:59. PubMed
  36. Nguyen TM, et al. 2020. Nucleic Acids Res. 48:2621. PubMed
  37. Michelena J, et al. 2018. Nat Commun. 9:2028. PubMed
  38. Guo Y, et al. 2022. iScience. 25:104519. PubMed
  39. Lee S, et al. 2021. Nat Commun. 12:6309. PubMed
  40. Jelinkova S, et al. 2021. Int J Mol Sci. 22: . PubMed
  41. Qin Y, et al. 2019. Mol Oncol. 13:1419. PubMed
  42. Wang Z, et al. 2019. J Biol Chem. 294:3909. PubMed
  43. Mochizuki K, et al. 2008. J Cell Sci. 121:2148. PubMed
  44. Mochizuki J 2009. Mol Biol Cell. 2.519444444. PubMed
  45. Martinelli P, et al. 2011. Blood. 117:6617. PubMed
  46. Ga?án-Gómez I, et al. 2022. Nat Med. . PubMed
  47. Cuella-Martin R, et al. 2021. Cell. 184(4):1081-1097.e19. PubMed
  48. Michelena J, et al. 2019. J Cell Biol. 218:2865. PubMed
  49. Lezaja A, et al. 2021. Nat Commun. 12:3827. PubMed
  50. Oshima K, et al. 2020. Nat Cancer. 1:1113. PubMed
  51. Titus S, et al. 2013. Sci Transl Med. 13:21. PubMed
  52. Delaney JR, et al. 2020. PLoS Genet. 16:e1008558. PubMed
  53. Saxena S et al. 2018. Cell reports. 25(12):3273-3282 . PubMed
  54. Sang M, et al. 2018. Oncol Rep. 39:2749. PubMed
  55. Ueno H, et al. 2022. Commun Biol. 5:571. PubMed
  56. Paculova H, et al. 2017. Tumour Biol. 39:1010428317727479. PubMed
  57. Hjorth–Jensen K, et al. 2018. Nucleic Acids Res. 46:9484. PubMed
  58. Mlcochova P,et al. 2017. EMBO J.. 10.15252/embj.201796880. PubMed
  59. Furia L, et al. 2022. Front Oncol. 12:960734. PubMed
  60. Switonski PM, et al. 2021. Cell Rep. 37:110062. PubMed
  61. Kychygina A, et al. 2021. Sci Rep. 11:13195. PubMed
  62. Kim C, et al. 2021. Nat Commun. 12:1097. PubMed
  63. Kim IK, et al. 2020. Cell Death Differ. 27:2263. PubMed
  64. Sakata R, et al. 2021. Cell Reports. 35(4):108999. PubMed
  65. Stobezki R, et al. 2020. Reprod Sci. 27:940. PubMed
  66. Udugama M, et al. 2015. Nucleic Acids Res. 43: 10227 - 10237. PubMed
  67. Sandoval P, et al. 2015. PLoS Genet. 11: 1005405. PubMed
  68. Pellegrino S, et al. 2017. Cell Reports. 10.1016/j.celrep.2017.05.016. PubMed
  69. Furia L, et al. 2022. Int J Mol Sci. 23:. PubMed
  70. Perucca P et al. 2018. Biochimica et biophysica acta. 1865(6):898-907 . PubMed
  71. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  72. Garg J, et al. 2020. Current Biology. 29(14):2371-2379. PubMed
  73. Przetocka S, et al. 2018. Mol Cell. 72:568. PubMed
  74. Akbay E, et al. 2008. Am J Pathol. 173:536. PubMed
  75. Crown K, et al. 2013. g3. 3:1927. PubMed
  76. Zhdanova N, et al. 2014. Mol Cell Biol. 34:2786. PubMed
  77. Swift ML, et al. 2021. Cell Reports. 34(11):108840. PubMed
  78. Valianatos G,et al. 2017. PLoS One. 10.1371/journal.pone.0185801. PubMed
  79. Akematsu T et al. 2017. eLife. 6 pii: e26176. PubMed
  80. Massignan T, et al. 2010. J Biol Chem. 285:7752. PubMed
  81. Widodo N, et al. 2010. PLoS One. 5:e13536. PubMed
  82. Hirano J 2011. J Cell Biol. 192:263. PubMed
  83. Suzuki K, et al. 2010. Nucleic Acids Res. 38:e129. PubMed
  84. Xu Y, et al. 2020. Oncol Rep. 44:1455. PubMed
  85. Prendergast L, et al. 2020. Nat Commun. 3.606944444. PubMed
  86. Yamauchi S, et al. 2017. BMC Cancer. 10.1186/s12885-017-3621-x. PubMed
  87. Ogata T, et al. 2017. PLoS One. 10.1371/journal.pone.0179884. PubMed
  88. Amrenova A, et al. 2021. PLoS One. 16:e0249059. PubMed
RRID
AB_315794 (BioLegend Cat. No. 613401) AB_315795 (BioLegend Cat. No. 613402)

Antigen Details

Structure
Basal histone, H2 histone family; 14 kD
Distribution

Nuclear

Function
Phosphorylated H2AX promotes DNA repair and maintains genomic stability. Important for recombination between immunoglobulin switch regions
Modification
Phosphorylation on Ser139 after double-stranded DNA breaks
Biology Area
Cell Biology, Chromatin Remodeling/Epigenetics, DNA Repair/Replication, Neuroscience
Molecular Family
Phospho-Proteins
Antigen References

1. Mannironi C, et al.1989. Nucleic Acids Res. 17:9113.
2. Celeste A, et al. 2002. Science 296:922.
3. Bassing CH, et al. 2002. Proc. Natl. Acad. Sci. USA 99:8173.
4. Reina-San-Martin B, et al. 2003. J. Exp. Med. 197:1767.

Regulation
Synthesized in G1 and S-phase of cell cycle
Gene ID
3014 View all products for this Gene ID
UniProt
View information about Phosphorylated H2A.X on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线